1. Asher A, Mulé JJ, Reichert CM, Shiloni A, Rosenberg SA. Studies on the antitumor efficacy of systemically administered recombinant tumor necrosis factor against several murine tumors in vivo.J Immunol 1987;138:963–74.
2. Blick M, Sherwin SA, Rosenblum M. I study of recombinant tumor necrosis factor in cancer patients.Cancer Res 1987;47:2986.
3. Chapman PB, Lester TJ, Casper ES, et al. Phase I study of recombinant tumor necrosis factor (rTNF).Proc ASCO 1986;5:231.
4. Khan A, Pardue A, Aleman C, et al. Phase I clinical trial with recombinant tumor necrosis factor (TNF).Proc ASCO 1986;5:226.
5. Fraker DL. Biologic therapy with tumor necrosis factor: clinical applications by systemic and regional administration. In: Rosenberg SA, ed.Biological therapy of cancer. Philadelphia, PA: JB Lippincott, 1994.